WASHINGTON — Pfizer and BioNTech announced on Tuesday that they had submitted data to the Food and Drug Administration that the companies said showed their coronavirus vaccine is safe and effective in children ages 5 to 11.The companies said they would submit a formal request to regulators to allow a pediatric dose of their vaccine…
